Related Experiment Video

Updated: Aug 6, 2026

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
10:46

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models

Published on: May 3, 2017

Glutamate in current paediatric amino acid solutions is not toxic

Frank Pohlandt1

  • 1Section of Neonatology and Paediatric Critical Care, Children's Hospital, University of Ulm, Ulm, Germany. frank.pohlandt@uni-ulm.de

Acta Paediatrica (Oslo, Norway : 1992)
|August 3, 2006
PubMed

Insights

High-dose glutamate can harm infant brains, but this risk is not applicable to parenteral nutrition. Continuous, low-dose infusion in neonates does not elevate plasma glutamate levels, refuting prior concerns.

Area of Science:

  • Neonatal nutrition
  • Neuroscience
  • Biochemistry

Background:

  • A previous article questioned the safety of glutamate in paediatric parenteral nutrition.
  • Concerns were raised regarding potential neurotoxicity in newborn infants.

Discussion:

  • Animal studies showing neurotoxicity used high bolus doses of glutamate, which differ from continuous infusion methods.
  • Parenteral nutrition involves constant, low-dose glutamate infusion over 24 hours.
  • Clinical data demonstrating maintained plasma glutamate levels within the reference range during parenteral nutrition were overlooked.

Key Insights:

  • The neurotoxic effects of high-dose glutamate in animal models cannot be directly extrapolated to neonatal parenteral nutrition.
  • Continuous infusion of glutamate in parenteral nutrition does not lead to harmful plasma concentrations in infants.
  • Previous alarms regarding glutamate toxicity in this context lack substantial evidence.

Outlook:

  • Further research should focus on the specific pharmacokinetics and safety profiles of nutrients in neonatal parenteral nutrition.
  • Clinical guidelines should be based on evidence from human studies rather than extrapolations from animal models.
  • Reassurance for neonatologists regarding the safe use of glutamate in parenteral nutrition is warranted.
Abstract

More Related Videos

Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain08:23

Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain

Published on: May 12, 2018

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Physical Properties of Amines01:26

Physical Properties of Amines

Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...